Boston Scientific (BSX) Accounts Payables (2009 - 2026)

Boston Scientific has disclosed Accounts Payables across 18 years of filings, most recently posting $1.2 billion for Q2 2026.

• In Q2 2026, Accounts Payables rose 27.96% year-over-year to $1.2 billion; the TTM figure through Jun 2026 stood at $1.2 billion (up 27.96% YoY), while the FY2025 annual figure was $1.1 billion, up 19.17% from the prior year.
• Accounts Payables came in at $1.2 billion for Q2 2026 at Boston Scientific, up from $1.1 billion in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $1.2 billion in Q2 2026 to a low of $696.0 million in Q1 2022.
• Average Accounts Payables over 5 years is $939.4 million, with a median of $925.0 million recorded in 2023.
• Year-over-year, Accounts Payables dropped 2.37% in 2024 and climbed 27.96% in 2026.
• Over 5 years, Accounts Payables stood at $862.0 million in 2022, then increased by 9.28% to $942.0 million in 2023, then advanced by 1.91% to $960.0 million in 2024, then increased by 19.17% to $1.1 billion in 2025, then grew by 7.6% to $1.2 billion in 2026.
• Per Business Quant data, the three most recent Accounts Payables figures were $1.2 billion in Q2 2026, $1.1 billion in Q1 2026, and $1.1 billion in Q4 2025.